Please ensure Javascript is enabled for purposes of website accessibility

Earnings Highlights for CVS Health and MercadoLibre

By Motley Fool Staff - May 18, 2016 at 11:03AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A discussion of what is driving MercadoLibre’s exciting growth and how investors can measure performance of companies that deal with relatively volatile currency.

In this clip from the Motley Fool Money radio show, Chris Hill, Ron Gross, and Matt Argersinger talk about first-quarter earnings for MercadoLibre (MELI 5.84%) and CVS Health (CVS 2.33%).

There are several levers CVS pulled this quarter, and thanks to the help of some acquired pharmacies, the stock in enjoying a little pop after earnings.

With MercadoLibre, growth numbers look good, particularly if you focus on non-currency metrics like registered users, items sold, and transactions on MercadoPago.

A transcript follows the video.

This podcast was recorded on May 6, 2016. 

Chris Hill: First-quarter profit and revenue for CVS Health coming in a little bit higher than expected, and the stock moving a little bit higher, too, Ron.

Ron Gross: The company is doing well, benefiting from all those Target pharmacies they took on, and the acquisition of Omnicare. Same-store sales are up 4%. Margins took a hit, what we call reimbursement pressure continuing to weigh, some of their product mix hurting margins. So, adjusted EPS was only up 4%, but pretty good. Guidance a bit weak, but reiterated full-year. So I would say everything's on track, company continues to execute well.

Hill: MercadoLibre is the most popular e-commerce business in Latin America. First-quarter results were surprising, but in a good way, Matty.

Matt Argersinger: Surprising in a good way. It's tough to follow the top-line earnings results for this company, because the currencies they deal with in Latin America are so volatile against the U.S. dollar. Three metrics I really like to use -- if you look at registered users, those are up 20% to 152 million. They're by far the leader in e-commerce in the region. Items sold is kind of my proxy for revenue growth up 39% to 38 million units. Also, transactions on MercadoPago, which is their PayPal-like platform, up 86% to 27.5 million, which gives you an idea of the velocity of transactions across MercadoLibre's platform. I love this company. I think if you really want to play e-commerce in emerging markets, this is probably your best bet.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$94.52 (2.33%) $2.15
Mercadolibre, Inc. Stock Quote
Mercadolibre, Inc.
MELI
$739.46 (5.84%) $40.82

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.